COVID-19 Experiences in the SELF Cohort
Enrolling by invitation
1,668 enrolled
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitation
64,277 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
1,150 enrolled
Data Collection, Clinical Care and Interventions in CCR, NCI
Enrolling by invitation
10,000 enrolled
Biology Studies of Hematologic Cancers
Enrolling by invitation
550 enrolled
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
Enrolling by invitation
100 enrolled
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Enrolling by invitation
120 enrolled
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
Enrolling by invitation
1,000 enrolled
Screening for Hematology Branch Protocols
Enrolling by invitation
10,000 enrolled
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
Enrolling by invitation
1,000 enrolled
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Enrolling by invitation
500 enrolled
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
Enrolling by invitation
10,000 enrolled
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
Enrolling by invitation
500 enrolled
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Enrolling by invitation
1,000 enrolled
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by invitation
1,200 enrolled